Scientists probe Hormone's role in Weight-Loss surgery success

NCT ID NCT07212868

Recruiting now Knowledge-focused Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how the hormone glucagon controls blood sugar in people who have had weight-loss surgery compared to those who haven't. Researchers will give participants an experimental drug that blocks glucagon's effects and measure their blood sugar response to meals. The goal is to gather basic knowledge about metabolism, not to treat or cure any disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-DIABETIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Texas Diabetes Institute - University Health System
RECRUITING

San Antonio, Texas, 78207, United States

Contact

Contact Email: •••••@•••••

Contact Email: •••••@•••••
University of Texas San Antonio
RECRUITING

San Antonio, Texas, 78229, United States

Contact

Contact Email: •••••@•••••

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON-DIABETIC